Dr Reddys Laboratories Shares Experience Volume Surge, Up by 1.18%
Dr Reddys Laboratories' shares reflect a positive movement amid high trading volumes during today's session. The company's consistent financial performance and key financial indicators suggest stability.
Alpha Desk
April 30, 2025 / 15:53 IST
DisclaimerThis is an AI-assisted live blog with updates sourced from multiple news outlets and agenciesDisclaimer
Dr Reddy's Share Price Today
Dr Reddys Laboratories shares experienced a notable surge in trading volume during today's session, accompanied by a 1.18% increase in price intraday, reaching Rs 1190.00. The increased activity suggests heightened investor interest in the pharmaceutical company.
The stock is part of the NIFTY 50 index, indicating its significance in the Indian stock market. This index membership reflects the company's substantial market capitalization and influence.
An overview of Dr Reddys Laboratories' financial performance reveals the following trends:
Quarterly Performance:
December 2023: Revenue was Rs 7,236.80 Cr, with a net profit of Rs 1,378.20 Cr and an EPS of Rs 82.94.
March 2024: Revenue was Rs 7,113.80 Cr, with a net profit of Rs 1,306.30 Cr and an EPS of Rs 78.66.
June 2024: Revenue increased to Rs 7,696.10 Cr, with a net profit of Rs 1,386.50 Cr and an EPS of Rs 83.61.
September 2024: Revenue further rose to Rs 8,038.20 Cr, while net profit stood at Rs 1,335.80 Cr and EPS at Rs 80.45.
December 2024: The company reported revenue of Rs 8,381.20 Cr, a net profit of Rs 1,400.00 Cr, and an EPS of Rs 16.97.
Annual Performance:
2020: Revenue was Rs 17,517.00 Cr, with a net profit of Rs 1,969.90 Cr and an EPS of Rs 122.22.
2021: Revenue increased to Rs 19,047.50 Cr, while net profit was Rs 1,903.60 Cr and EPS was Rs 117.67.
2022: Revenue further rose to Rs 21,545.20 Cr, with a net profit of Rs 2,112.20 Cr and an EPS of Rs 131.57.
2023: The company reported revenue of Rs 24,669.70 Cr, a net profit of Rs 4,470.30 Cr, and an EPS of Rs 271.47.
2024: Revenue reached Rs 28,011.10 Cr, with a net profit of Rs 5,563.20 Cr and an EPS of Rs 335.22.
The company’s book value per share has consistently increased from Rs 938.56 in 2020 to Rs 1,693.93 in 2024. The Return on Equity (ROE) has also shown positive trends, with 19.74 in 2024. The debt-to-equity ratio remains low at 0.06 in 2024.
